Low and High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Resistant Auditory Hallucination in Schizophrenia
NCT ID: NCT02175251
Last Updated: 2023-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
33 participants
INTERVENTIONAL
2014-02-28
2017-09-29
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Schizophrenia : a Randomized Controlled Study
NCT01022489
Efficacy of Maintenance Repetitive Transcranial Magnetic Stimulation (rTMS) in Auditory Verbal Hallucinations
NCT05550155
Interest of Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Auditory Hallucinations
NCT02525315
Structural and Functional Correlates of Clinical Response to rTMS Treatment in Schizophrenia Patients With Resistant Auditory Hallucinations
NCT02755623
Repetitive Transcranial Magnetic Stimulation for Refractory Auditory Hallucinations in Schizophrenia
NCT01386918
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
low frequency (1Hz)
low frequency
low frequency (1Hz)
10 session in 5 days with low frequency (1Hz)
Sham Comparator
Sham Comparator
Sham Comparator
10 session in 5 days with sham-controlled
high frequency (20Hz)
high frequency
high frequency (20Hz)
10 session in 5 days with high frequency (20 Hz)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
high frequency (20Hz)
10 session in 5 days with high frequency (20 Hz)
low frequency (1Hz)
10 session in 5 days with low frequency (1Hz)
Sham Comparator
10 session in 5 days with sham-controlled
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* rTMS contraindications
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Assistance Publique - Hôpitaux de Paris
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Caroline DUBERTRET, PU-PH
Role: STUDY_DIRECTOR
Department of Psychiatry, Louis MOURIER Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Psychiatry, Louis Mourier Hospital
Colombes, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IDRCB 2013-A00872-43
Identifier Type: OTHER
Identifier Source: secondary_id
P120909
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.